New Federal Regulations on Drug Testing: Key Changes for Employers
Federal Bill H. R. 6. the “Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act” or the “Support for Patients and Communities Act,” was signed into law on Wednesday, October 24, 2018, by President Trump. This legislation introduced significant changes to Federal drug testing regulations, particularly for DOT-mandated drug [...]